
Antimicrobial Resistance
Studies on sepsis
We are interested in hospital-acquired, healthcare-associated and community-acquired sepsis.
Towards this, we collaborate with several healthcare facilities to:
a) Analyse antibiogram trends
b) Examine blood culture patterns and AMR genotypes
c) Perform retrospective and prospective examinations of hospital EMRs to distinguish between the three types of sepsis and study the epidemiology and presentation.
d) Compare pharmaceutical prescription patterns to improve antimicrobial stewardship
Funded by many organisations, including Biome Environmental Trust &Swasti Health Catalyst
AMR patterns and pharmaceutical compounds in environmental samples, including lake waters and open drains
Funded by DST IMPRINT, in collaboration with IISc: 2019-22
MSCH was the industry partner on a multi-site, interdisciplinary project to rapidly detect pathogens in ICU patients suspected to have blood stream infections. In addition to detection, we also aim to detect antimicrobial resistance genes which will help doctors decide which antibiotics might be needed and which antibiotics need not be used.
Funded by BIRAC: 2018-2020
MSCH was awarded the Biotechnology Ignition Grant (BIG) in 2018 for developing HIV drug resistance genotyping tests and HIV viral load tests in dried blood spots.